Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study.
Motte J, Fisse AL, Köse N, Grüter T, Mork H, Athanasopoulos D, Fels M, Otto S, Siglienti I, Schneider-Gold C, Hellwig K, Yoon MS, Gold R, Pitarokoili K.
Motte J, et al. Among authors: siglienti i.
Ther Adv Neurol Disord. 2021 Mar 5;14:1756286421999631. doi: 10.1177/1756286421999631. eCollection 2021.
Ther Adv Neurol Disord. 2021.
PMID: 33747132
Free PMC article.